A Pilot Clinical Study of the Efficacy and Safety of a Disposable Intravaginal Device for Stress Urinary Incontinence

NCT ID: NCT01762345

Last Updated: 2016-03-24

Study Results

Results available

Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.

View full results

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

148 participants

Study Classification

INTERVENTIONAL

Study Start Date

2012-12-31

Study Completion Date

2013-07-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This pilot study will evaluate the efficacy of the pessary (disposable intra-vaginal device) by reduction in urine leakage in women with stress urinary incontinence (SUI).

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Stress Urinary Incontinence

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NA

Intervention Model

SINGLE_GROUP

Primary Study Purpose

TREATMENT

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

pessary device

pessary (disposable intra-vaginal device)

Group Type EXPERIMENTAL

pessary (disposable intra-vaginal device)

Intervention Type DEVICE

pessary device(disposable intra-vaginal device)manufactured by Procter \& Gamble

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

pessary (disposable intra-vaginal device)

pessary device(disposable intra-vaginal device)manufactured by Procter \& Gamble

Intervention Type DEVICE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* have a ≥ 3 month history of experiencing Stress Urinary Incontinence
* be willing to use the pessary investigational device to control stress incontinence

Exclusion Criteria

* pregnant, lactating or planning to become pregnant during the study
* within 3 months post partum
* intrauterine device (IUD) placement of less than 6 months
* a history of Toxic Shock Syndrome (TSS) or symptoms consistent with TSS
* experience difficulty inserting or wearing an intra-vaginal device, including a tampon
* vaginal surgery, perineal surgery, uterine surgery, or abortion (spontaneous or induced) within the past 3 months
* has any Screening laboratory value outside the laboratory reference range considered clinically significant by the Investigator
* for any reason, the Investigator decides that the subject should not participate in the study
Minimum Eligible Age

18 Years

Eligible Sex

FEMALE

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Procter and Gamble

INDUSTRY

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Randall Severance, MD

Role: PRINCIPAL_INVESTIGATOR

Radiant Research, Inc.

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Study Center

Chandler, Arizona, United States

Site Status

Countries

Review the countries where the study has at least one active or historical site.

United States

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

2012099

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.